Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting MHC-I inhibitory pathways for cancer immunotherapy
Jun Wang, Lu Qiao, Xufeng Chen, et al.
Trends in Immunology (2024) Vol. 45, Iss. 3, pp. 177-187
Closed Access | Times Cited: 11

Showing 11 citing articles:

“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
Lingjun Xiao, Louqian Zhang, Ciliang Guo, et al.
Cancer Communications (2024) Vol. 44, Iss. 7, pp. 791-832
Open Access | Times Cited: 5
Norepinephrine (NE) promotes activated B cells to identify and kill effector CD8+ T cells through FasL/Fas pathway in spleen mononuclear cells isolated from experimental autoimmune encephalomyelitis (EAE)
Wei Huang, Jing Wang, Chao Liu, et al.
Brain Behavior and Immunity (2025) Vol. 125, pp. 294-307
Open Access
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling
Xiaowei Zhang, Yang Zhao, Chen Xu
Translational Oncology (2024) Vol. 49, pp. 102113-102113
Open Access | Times Cited: 4
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Editorial: Specific targeting of MHC antigens for T-cells and immune cells in human disease
Ali Afzal, Muhammad Babar Khawar, Weijuan Gong, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
A pan-cancer analysis reveals the oncogenic and immunological role of insulin-like growth factor 2 mRNA-binding protein family members
Fangfang Zeng, Liuyan Chen, Jing Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy
Yinghao Ding, Shengyi Zhang, Wei Li, et al.
Nano Letters (2024) Vol. 24, Iss. 24, pp. 7397-7407
Closed Access | Times Cited: 3
Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface
Jin Soo Joo, Dongeun Lee, Jun Young Hong
Immune Network (2024) Vol. 24, Iss. 4
Open Access | Times Cited: 1
Mechanisms of Low MHC I Expression and Strategies for Targeting MHC I with Small Molecules in Cancer Immunotherapy
S. W. Kong, Jie Zhang, Longsheng Wang, et al.
Cancer Letters (2024) Vol. 611, pp. 217432-217432
Closed Access | Times Cited: 1
PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinoma
Liang Han, Mingming Tang, Zihao Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top